NEUROPHARMAGEN
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NEUROPHARMAGEN, covering 2024-02-05 to 2024-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients [Phase 3]